11,603 Shares in Colgate-Palmolive Company $CL Purchased by Transamerica Financial Advisors LLC

Transamerica Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the second quarter, HoldingsChannel reports. The institutional investor purchased 11,603 shares of the company’s stock, valued at approximately $1,064,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Norges Bank acquired a new position in Colgate-Palmolive in the fourth quarter valued at about $861,670,000. Bank of New York Mellon Corp grew its position in shares of Colgate-Palmolive by 172.5% during the 1st quarter. Bank of New York Mellon Corp now owns 12,521,545 shares of the company’s stock worth $1,067,211,000 after buying an additional 7,927,238 shares during the period. Bank of America Corp DE bought a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at $567,483,000. Northwestern Mutual Wealth Management Co. lifted its stake in Colgate-Palmolive by 8,040.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock valued at $380,666,000 after buying an additional 4,598,789 shares during the period. Finally, Balyasny Asset Management L.P. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $236,682,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on CL. Royal Bank Of Canada raised their price target on Colgate-Palmolive from $102.00 to $104.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a research note on Monday, August 3rd. Piper Sandler upped their target price on Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $99.00.

Insider Transactions at Colgate-Palmolive

In other news, Director John T. Cahill sold 4,170 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. The trade was a 12.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Noel R. Wallace sold 161,021 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the transaction, the chief executive officer owned 362,231 shares in the company, valued at $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 175,191 shares of company stock valued at $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Trading Up 0.9%

Shares of NYSE CL opened at $92.12 on Thursday. The stock has a market cap of $73.44 billion, a P/E ratio of 36.56, a price-to-earnings-growth ratio of 4.27 and a beta of 0.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The firm has a 50 day moving average price of $91.98 and a two-hundred day moving average price of $90.08. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The firm had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. During the same period in the previous year, the business earned $0.92 EPS. The business’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.86 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, July 20th were paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.